Skip to content

Sotera Health SHC Return on equity

Return on equity at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
-6%
STERIS logo
STERISSTE
11.3%+1.8pp
Fortive logo
FortiveFTV
6.7%-1.0pp
Balchem logo
BalchemBCPC
12.7%+0.7pp
Natera, Inc. logo
Natera, Inc.NTRA
-29%+4.1pp
Oklo logo
OkloOKLO
-8.9%

Other financials

Income statement

See full
Revenue$280.0M+10.0%
Gross profit$147.1M+8.6%
Operating income$87.1M-16.2%
Net income$26.6M+301%
EPS (diluted)$0.09+280%

Balance sheet

See full
Cash & equivalents$314.1M+3.2%
Total debt$2.3B-3.2%
Total equity$622.5M+50.3%
Total assets$3.2B+4.5%

Cash flow

See full
Operating cash flow$29.4M-47.0%
CapEx$46.2M+132%
Free cash flow-$16.7M-147%

Valuation

See full
Market cap$4.51B+23.4%
Enterprise value$6.47B+12.8%
P/E38.3×-109×
P/S3.8×+0.5×

Profitability

See full
Gross margin55.3%+0.1pp
Operating margin27%+0.7pp
Net margin9.9%+7.7pp
FCF margin8.1%

Returns & leverage

See full
Debt / equity3.6×-2.0×
Current ratio2.8×+0.4×

Where this comes from

Calculated from Sotera Health’s reported figures.

Based on trailing twelve months.

The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sotera Health's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sotera Health's return on equity?
Sotera Health (SHC) reported return on equity of 22.7% in Q1 2026.
How has Sotera Health's return on equity changed year-over-year?
Sotera Health's return on equity increased by 286.3% year-over-year, from 5.9% to 22.7%.
What is the long-term trend for Sotera Health's return on equity?
Over 4 years (2021 to 2025), Sotera Health's return on equity has grown at a -9.0% compound annual growth rate (CAGR), from 22.5% to 15.4%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.